MilliporeSigma was created after Germany-based Merck acquired the former Millipore Corp. The company’s comprehensive service portfolio combines the steps of drug development and production into a single source, helping reduce risk and streamlining the process of getting therapies to patients faster.
Whether you need customized or ready-to-use solutions, our team of quality and regulatory experts will tailor solutions to precisely fit your process needs. Your Role: The Quality Assurance Associate at MilliporeSigma works within the Milwaukee QA team to ensure. With more than 35 years of experience in the development and manufacturing of small molecules, biologics and ADC technologies, MilliporeSigma offers extensive experience in both clinical and commercial manufacturing. Our complete portfolio of high-performance cGMP raw material solutions spans cell culture, process chemicals, formulation and HPAPI/ADC contract manufacturing. Hybrid role (Onsite 2-3 days a week in Milwaukee WI). Responsible for the preparation and evaluation of chemical combinations for all phases of manufacturing, production. “Companies have a choice when deciding to expand, and MilliporeSigma’s decision to invest in Verona is a testament to Wisconsin’s strong business climate and dedicated workforce.”
“Wisconsin is proud to have innovative and forward-thinking companies like MilliporeSigma develop here,” said Missy Hughes, secretary and CEO of WEDC. Last updated on January 3rd, 2022 at 01:04 pmMilliporeSigma announced plans this week to build a new lateral flow membrane production facility in Sheboygan County after landing a 136.7 million. WEDC has authorized up to $200,000 in state income tax credits over the next three years, contingent upon the number of jobs created. These additions will accommodate projected growth and provide an audit-ready facility that meets customer and internal quality requirements. The company’s expansion plans include increasing the company’s antibody-drug conjugate (ADC) manufacturing capacity and adding a 70,000-square-foot highly potent active pharmaceutical ingredient manufacturing facility. Together, we impact life and health with science. Life science company MilliporeSigma said Monday it opened its new 65 million, high-potent active pharmaceutical ingredients production facility in Verona, bringing 50 new jobs to the Madison area. MilliporeSigma, an industry-leading life sciences company that provides contract pharmaceutical manufacturing services, currently has four biochemical production and pharmaceutical ingredient manufacturing facilities in Wisconsin-and recently announced a $65 million expansion of the facility, in Verona, Wisconsin, a project expected to create approximately 50 new jobs starting this year.
0 kommentar(er)
